Top compounds associated with response to XCL1


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.057 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.019 0.6
mRNA tivozanib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC -0.034 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.008
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.004 0.9
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.024 0.5
mRNA triptolide CTRPv2 pan-cancer AAC -0.0056 0.9
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.067 0.2
Download CSV